What are the latest advancements in non-surgical treatments for keratoconus and their efficacy rates?

[sanjayko...@gmail.com]

Keratoconus Treatment has witnessed significant advancements in recent years, particularly in non-surgical approaches aimed at halting disease progression and improving vision. Keratoconus is a progressive eye condition where the cornea, the clear front surface of the eye, thins and bulges outward into a cone shape. This irregular shape distorts vision, causing blurriness, increased light sensitivity, and halos around lights. While surgical interventions like corneal transplants are reserved for advanced cases, non-surgical treatments play a crucial role in managing the condition, especially in its early to moderate stages.

Corneal Collagen Cross-Linking (CXL)

Corneal Collagen Cross-Linking (CXL) stands out as a primary advancement in non-surgical Keratoconus Treatment. This minimally invasive procedure aims to strengthen the cornea and prevent further progression of the condition. The standard "Dresden protocol" involves removing the outer layer of the cornea (epithelium), applying riboflavin (vitamin B2) eye drops, and then exposing the cornea to ultraviolet-A (UV-A) light for a specific duration. This process encourages the formation of new collagen cross-links within the cornea, making it more rigid and less likely to bulge further.

Efficacy Rates: Studies indicate that CXL is highly effective in halting the progression of keratoconus in approximately 90% of treated eyes. In some cases, patients also experience an improvement in visual acuity and corneal shape. Long-term follow-up data suggests that the stabilization effect of CXL can last for many years, potentially reducing or eliminating the need for corneal transplantation.

Variations in CXL:

• Epithelium-Off (Epi-Off) CXL: The traditional method, considered more effective for advanced cases.
• Epithelium-On (Epi-On) CXL: A less invasive approach that preserves the epithelium, potentially leading to faster healing and reduced discomfort. However, its efficacy might be lower in advanced cases due to limited riboflavin penetration. Recent advancements are focusing on enhancing riboflavin penetration in Epi-On CXL using techniques like iontophoresis and penetration enhancers.
• Accelerated CXL: This variation uses a higher intensity of UV-A light for a shorter duration, aiming to achieve similar results to the standard protocol with reduced treatment time. Studies suggest comparable stabilization rates to conventional CXL.
• Pulsed CXL: This technique involves cycles of UV-A light application with pauses, which may improve oxygen availability in the cornea during the procedure and potentially enhance the cross-linking effect.

Customised Contact Lens Technology

Advancements in contact lens technology offer significant improvements in vision correction for individuals with keratoconus. These lenses work by providing a smooth, regular refractive surface over the irregular cornea.

• Rigid Gas Permeable (RGP) Lenses: These were traditionally the mainstay for keratoconus. They provide excellent vision correction by masking the irregular corneal shape. While effective, some patients find them uncomfortable initially. Success rates for vision enhancement are reported to be high, ranging from 80-90% in early to moderate stages.
• Hybrid Lenses: These lenses combine a rigid central zone for sharp vision with a soft outer skirt for improved comfort. They can be a good alternative for those who find RGP lenses uncomfortable.
• Piggyback Lenses: This involves wearing a hard contact lens over a soft contact lens to improve comfort while maintaining the visual benefits of a rigid lens.
• Scleral Lenses: These large-diameter rigid lenses rest on the sclera (the white of the eye) and vault over the cornea, creating a tear-filled space that neutralizes the irregular corneal surface. Scleral lenses are often very comfortable and provide excellent vision, especially in more advanced or irregular keratoconus. They have become a popular option due to their comfort and visual outcomes. First-fit success rates with advanced fitting technologies can be around 52%, with second fittings reaching 85% success.
• Custom Soft Contact Lenses: While traditional soft lenses are less effective for keratoconus, advancements in custom designs allow for better fitting and vision correction in mild to moderate cases.

Topography-Guided Treatments

Corneal topography, a detailed mapping of the corneal surface, plays an increasingly important role in planning and optimizing non-surgical Keratoconus Treatment.

• Topography-Guided Contact Lens Fitting: Precise corneal maps help in designing and fitting specialized contact lenses, ensuring optimal comfort and vision correction.
• PTK-Assisted Customized Epi-On Corneal Cross-Linking (PACE): This emerging technique combines phototherapeutic keratectomy (PTK), a laser procedure to remove a tiny layer of the epithelium based on the corneal map, with Epi-On CXL. This approach aims to improve riboflavin penetration and potentially enhance both the stabilization of keratoconus and visual outcomes. Early clinical trials show promising results in corneal flattening and visual acuity improvement.

Emerging Research

Ongoing research continues to explore novel non-surgical approaches for Keratoconus Treatment:

• Pharmacological Treatments: Studies are investigating the potential of pharmacological agents, such as copper sulfate eye drops (IVMED-80), to prevent keratoconus progression. These are currently undergoing clinical trials.
• Gene Therapy: Research into the genetic components of keratoconus opens possibilities for future gene therapies that could target the underlying causes of the condition.
• Extracellular Vesicles: Early research suggests that extracellular vesicles, particularly exosomes derived from corneal stromal mesenchymal stem cells, may have therapeutic potential in corneal tissue regeneration and repair in keratoconus.

In conclusion, the landscape of non-surgical Keratoconus Treatment is rapidly evolving. Corneal cross-linking remains a cornerstone in halting disease progression with high efficacy rates. Advancements in customized contact lenses, particularly scleral lenses, provide significant improvements in vision and comfort. Topography-guided approaches and emerging research offer promising avenues for even more personalized and effective management of this challenging condition. Early diagnosis and tailored treatment plans are crucial for maximizing the benefits of these advancements and improving the long-term visual outcomes for individuals with keratoconus.

Explore More Healthcare Reports and Gain Insights@

Embolic Protection Devices Market

Digital Health Market

Diagnostic Imaging Services Market

Clinical Alarm Management Market